In fact, two very recent studies on amyotrophic lateral sclerosis (ALS) demonstrated that TDP-43 was a significant biomarker for the disease, despite the fact that ALS does not result in significant or observable skin conditions [10, 11]. Here, TARDBP is linked to amyotrophic lateral sclerosis.